nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—SLC15A2—multiple sclerosis	0.835	1	CbGaD
Fosinopril—Spirapril—SLC15A2—multiple sclerosis	0.00159	0.246	CrCbGaD
Fosinopril—Cilazapril—SLC15A2—multiple sclerosis	0.00142	0.219	CrCbGaD
Fosinopril—Trandolapril—SLC15A2—multiple sclerosis	0.00137	0.212	CrCbGaD
Fosinopril—Ramipril—SLC15A2—multiple sclerosis	0.00137	0.212	CrCbGaD
Fosinopril—Ramipril—BCHE—multiple sclerosis	0.000719	0.111	CrCbGaD
Fosinopril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.000251	0.555	CbGpPWpGaD
Fosinopril—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000126	0.000794	CcSEcCtD
Fosinopril—Discomfort—Triamcinolone—multiple sclerosis	0.000125	0.000793	CcSEcCtD
Fosinopril—Discomfort—Methylprednisolone—multiple sclerosis	0.000125	0.000792	CcSEcCtD
Fosinopril—Headache—Azathioprine—multiple sclerosis	0.000125	0.000791	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000125	0.00079	CcSEcCtD
Fosinopril—Dry mouth—Triamcinolone—multiple sclerosis	0.000124	0.000785	CcSEcCtD
Fosinopril—Renal failure—Methotrexate—multiple sclerosis	0.000124	0.000784	CcSEcCtD
Fosinopril—Angioedema—Betamethasone—multiple sclerosis	0.000124	0.000782	CcSEcCtD
Fosinopril—Angioedema—Dexamethasone—multiple sclerosis	0.000124	0.000782	CcSEcCtD
Fosinopril—Confusional state—Methylprednisolone—multiple sclerosis	0.000122	0.000775	CcSEcCtD
Fosinopril—Malaise—Dexamethasone—multiple sclerosis	0.000122	0.000772	CcSEcCtD
Fosinopril—Malaise—Betamethasone—multiple sclerosis	0.000122	0.000772	CcSEcCtD
Fosinopril—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000122	0.00077	CcSEcCtD
Fosinopril—Oedema—Triamcinolone—multiple sclerosis	0.000122	0.00077	CcSEcCtD
Fosinopril—Vertigo—Betamethasone—multiple sclerosis	0.000122	0.000769	CcSEcCtD
Fosinopril—Vertigo—Dexamethasone—multiple sclerosis	0.000122	0.000769	CcSEcCtD
Fosinopril—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000121	0.000768	CcSEcCtD
Fosinopril—Syncope—Dexamethasone—multiple sclerosis	0.000121	0.000768	CcSEcCtD
Fosinopril—Syncope—Betamethasone—multiple sclerosis	0.000121	0.000768	CcSEcCtD
Fosinopril—Arrhythmia—Prednisone—multiple sclerosis	0.000121	0.000765	CcSEcCtD
Fosinopril—Infection—Triamcinolone—multiple sclerosis	0.000121	0.000765	CcSEcCtD
Fosinopril—Infection—Methylprednisolone—multiple sclerosis	0.000121	0.000763	CcSEcCtD
Fosinopril—Shock—Triamcinolone—multiple sclerosis	0.00012	0.000757	CcSEcCtD
Fosinopril—Insomnia—Prednisolone—multiple sclerosis	0.00012	0.000757	CcSEcCtD
Fosinopril—Shock—Methylprednisolone—multiple sclerosis	0.000119	0.000756	CcSEcCtD
Fosinopril—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000119	0.000752	CcSEcCtD
Fosinopril—Loss of consciousness—Betamethasone—multiple sclerosis	0.000119	0.000752	CcSEcCtD
Fosinopril—Epistaxis—Methotrexate—multiple sclerosis	0.000119	0.000752	CcSEcCtD
Fosinopril—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000119	0.000752	CcSEcCtD
Fosinopril—Paraesthesia—Prednisolone—multiple sclerosis	0.000119	0.000752	CcSEcCtD
Fosinopril—Tachycardia—Triamcinolone—multiple sclerosis	0.000119	0.000751	CcSEcCtD
Fosinopril—Nausea—Azathioprine—multiple sclerosis	0.000118	0.00075	CcSEcCtD
Fosinopril—Tachycardia—Methylprednisolone—multiple sclerosis	0.000118	0.00075	CcSEcCtD
Fosinopril—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000118	0.000744	CcSEcCtD
Fosinopril—Agranulocytosis—Methotrexate—multiple sclerosis	0.000118	0.000744	CcSEcCtD
Fosinopril—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000117	0.000743	CcSEcCtD
Fosinopril—Hypertension—Betamethasone—multiple sclerosis	0.000117	0.000739	CcSEcCtD
Fosinopril—Hypertension—Dexamethasone—multiple sclerosis	0.000117	0.000739	CcSEcCtD
Fosinopril—Asthenia—Mitoxantrone—multiple sclerosis	0.000116	0.000732	CcSEcCtD
Fosinopril—Myalgia—Betamethasone—multiple sclerosis	0.000115	0.000729	CcSEcCtD
Fosinopril—Myalgia—Dexamethasone—multiple sclerosis	0.000115	0.000729	CcSEcCtD
Fosinopril—Discomfort—Betamethasone—multiple sclerosis	0.000114	0.00072	CcSEcCtD
Fosinopril—Discomfort—Dexamethasone—multiple sclerosis	0.000114	0.00072	CcSEcCtD
Fosinopril—Haemoglobin—Methotrexate—multiple sclerosis	0.000114	0.000719	CcSEcCtD
Fosinopril—Hypotension—Methylprednisolone—multiple sclerosis	0.000113	0.000718	CcSEcCtD
Fosinopril—Pain—Prednisolone—multiple sclerosis	0.000113	0.000716	CcSEcCtD
Fosinopril—Hepatitis—Methotrexate—multiple sclerosis	0.000113	0.000716	CcSEcCtD
Fosinopril—Haemorrhage—Methotrexate—multiple sclerosis	0.000113	0.000716	CcSEcCtD
Fosinopril—Pharyngitis—Methotrexate—multiple sclerosis	0.000112	0.00071	CcSEcCtD
Fosinopril—Vision blurred—Prednisone—multiple sclerosis	0.000111	0.000702	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000111	0.000701	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000111	0.0007	CcSEcCtD
Fosinopril—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00011	0.000699	CcSEcCtD
Fosinopril—Oedema—Dexamethasone—multiple sclerosis	0.00011	0.000699	CcSEcCtD
Fosinopril—Oedema—Betamethasone—multiple sclerosis	0.00011	0.000699	CcSEcCtD
Fosinopril—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00011	0.000699	CcSEcCtD
Fosinopril—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00011	0.000698	CcSEcCtD
Fosinopril—Insomnia—Triamcinolone—multiple sclerosis	0.00011	0.000696	CcSEcCtD
Fosinopril—Insomnia—Methylprednisolone—multiple sclerosis	0.00011	0.000695	CcSEcCtD
Fosinopril—Infection—Betamethasone—multiple sclerosis	0.00011	0.000694	CcSEcCtD
Fosinopril—Infection—Dexamethasone—multiple sclerosis	0.00011	0.000694	CcSEcCtD
Fosinopril—Ill-defined disorder—Prednisone—multiple sclerosis	0.000109	0.000692	CcSEcCtD
Fosinopril—Paraesthesia—Triamcinolone—multiple sclerosis	0.000109	0.000691	CcSEcCtD
Fosinopril—Feeling abnormal—Prednisolone—multiple sclerosis	0.000109	0.00069	CcSEcCtD
Fosinopril—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000109	0.00069	CcSEcCtD
Fosinopril—Visual impairment—Methotrexate—multiple sclerosis	0.000109	0.00069	CcSEcCtD
Fosinopril—Anaemia—Prednisone—multiple sclerosis	0.000109	0.000689	CcSEcCtD
Fosinopril—Shock—Dexamethasone—multiple sclerosis	0.000109	0.000687	CcSEcCtD
Fosinopril—Shock—Betamethasone—multiple sclerosis	0.000109	0.000687	CcSEcCtD
Fosinopril—Dyspnoea—Triamcinolone—multiple sclerosis	0.000108	0.000686	CcSEcCtD
Fosinopril—Agitation—Prednisone—multiple sclerosis	0.000108	0.000685	CcSEcCtD
Fosinopril—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000108	0.000684	CcSEcCtD
Fosinopril—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000108	0.000684	CcSEcCtD
Fosinopril—Tachycardia—Betamethasone—multiple sclerosis	0.000108	0.000682	CcSEcCtD
Fosinopril—Tachycardia—Dexamethasone—multiple sclerosis	0.000108	0.000682	CcSEcCtD
Fosinopril—Angioedema—Prednisone—multiple sclerosis	0.000108	0.000681	CcSEcCtD
Fosinopril—Dyspepsia—Triamcinolone—multiple sclerosis	0.000107	0.000678	CcSEcCtD
Fosinopril—Erythema multiforme—Methotrexate—multiple sclerosis	0.000107	0.000677	CcSEcCtD
Fosinopril—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000107	0.000676	CcSEcCtD
Fosinopril—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000107	0.000675	CcSEcCtD
Fosinopril—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000107	0.000675	CcSEcCtD
Fosinopril—Malaise—Prednisone—multiple sclerosis	0.000106	0.000672	CcSEcCtD
Fosinopril—Vertigo—Prednisone—multiple sclerosis	0.000106	0.00067	CcSEcCtD
Fosinopril—Syncope—Prednisone—multiple sclerosis	0.000106	0.000668	CcSEcCtD
Fosinopril—Tinnitus—Methotrexate—multiple sclerosis	0.000105	0.000667	CcSEcCtD
Fosinopril—Anorexia—Dexamethasone—multiple sclerosis	0.000105	0.000666	CcSEcCtD
Fosinopril—Anorexia—Betamethasone—multiple sclerosis	0.000105	0.000666	CcSEcCtD
Fosinopril—Urticaria—Prednisolone—multiple sclerosis	0.000105	0.000665	CcSEcCtD
Fosinopril—Fatigue—Triamcinolone—multiple sclerosis	0.000105	0.000664	CcSEcCtD
Fosinopril—Fatigue—Methylprednisolone—multiple sclerosis	0.000105	0.000662	CcSEcCtD
Fosinopril—Pain—Triamcinolone—multiple sclerosis	0.000104	0.000658	CcSEcCtD
Fosinopril—Loss of consciousness—Prednisone—multiple sclerosis	0.000104	0.000655	CcSEcCtD
Fosinopril—Hypotension—Betamethasone—multiple sclerosis	0.000103	0.000653	CcSEcCtD
Fosinopril—Hypotension—Dexamethasone—multiple sclerosis	0.000103	0.000653	CcSEcCtD
Fosinopril—Vomiting—Mitoxantrone—multiple sclerosis	0.000103	0.000649	CcSEcCtD
Fosinopril—Hypertension—Prednisone—multiple sclerosis	0.000102	0.000644	CcSEcCtD
Fosinopril—Rash—Mitoxantrone—multiple sclerosis	0.000102	0.000643	CcSEcCtD
Fosinopril—Dermatitis—Mitoxantrone—multiple sclerosis	0.000102	0.000643	CcSEcCtD
Fosinopril—Chills—Methotrexate—multiple sclerosis	0.000101	0.000642	CcSEcCtD
Fosinopril—Headache—Mitoxantrone—multiple sclerosis	0.000101	0.000639	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000101	0.000636	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000101	0.000636	CcSEcCtD
Fosinopril—Myalgia—Prednisone—multiple sclerosis	0.0001	0.000635	CcSEcCtD
Fosinopril—Arthralgia—Prednisone—multiple sclerosis	0.0001	0.000635	CcSEcCtD
Fosinopril—Feeling abnormal—Triamcinolone—multiple sclerosis	0.0001	0.000634	CcSEcCtD
Fosinopril—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.0001	0.000633	CcSEcCtD
Fosinopril—Insomnia—Dexamethasone—multiple sclerosis	9.99e-05	0.000632	CcSEcCtD
Fosinopril—Insomnia—Betamethasone—multiple sclerosis	9.99e-05	0.000632	CcSEcCtD
Fosinopril—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.93e-05	0.000628	CcSEcCtD
Fosinopril—Paraesthesia—Dexamethasone—multiple sclerosis	9.91e-05	0.000627	CcSEcCtD
Fosinopril—Paraesthesia—Betamethasone—multiple sclerosis	9.91e-05	0.000627	CcSEcCtD
Fosinopril—Discomfort—Prednisone—multiple sclerosis	9.91e-05	0.000627	CcSEcCtD
Fosinopril—Hypersensitivity—Prednisolone—multiple sclerosis	9.75e-05	0.000617	CcSEcCtD
Fosinopril—Dyspepsia—Dexamethasone—multiple sclerosis	9.72e-05	0.000615	CcSEcCtD
Fosinopril—Dyspepsia—Betamethasone—multiple sclerosis	9.72e-05	0.000615	CcSEcCtD
Fosinopril—Urticaria—Triamcinolone—multiple sclerosis	9.67e-05	0.000612	CcSEcCtD
Fosinopril—Urticaria—Methylprednisolone—multiple sclerosis	9.64e-05	0.00061	CcSEcCtD
Fosinopril—Dysgeusia—Methotrexate—multiple sclerosis	9.64e-05	0.00061	CcSEcCtD
Fosinopril—Body temperature increased—Triamcinolone—multiple sclerosis	9.62e-05	0.000609	CcSEcCtD
Fosinopril—Anaphylactic shock—Prednisone—multiple sclerosis	9.61e-05	0.000608	CcSEcCtD
Fosinopril—Oedema—Prednisone—multiple sclerosis	9.61e-05	0.000608	CcSEcCtD
Fosinopril—Abdominal pain—Methylprednisolone—multiple sclerosis	9.6e-05	0.000607	CcSEcCtD
Fosinopril—Decreased appetite—Dexamethasone—multiple sclerosis	9.6e-05	0.000607	CcSEcCtD
Fosinopril—Decreased appetite—Betamethasone—multiple sclerosis	9.6e-05	0.000607	CcSEcCtD
Fosinopril—Nausea—Mitoxantrone—multiple sclerosis	9.58e-05	0.000606	CcSEcCtD
Fosinopril—Infection—Prednisone—multiple sclerosis	9.55e-05	0.000604	CcSEcCtD
Fosinopril—Fatigue—Dexamethasone—multiple sclerosis	9.52e-05	0.000602	CcSEcCtD
Fosinopril—Fatigue—Betamethasone—multiple sclerosis	9.52e-05	0.000602	CcSEcCtD
Fosinopril—Shock—Prednisone—multiple sclerosis	9.46e-05	0.000599	CcSEcCtD
Fosinopril—Pain—Betamethasone—multiple sclerosis	9.44e-05	0.000597	CcSEcCtD
Fosinopril—Pain—Dexamethasone—multiple sclerosis	9.44e-05	0.000597	CcSEcCtD
Fosinopril—Tachycardia—Prednisone—multiple sclerosis	9.38e-05	0.000594	CcSEcCtD
Fosinopril—Hyperhidrosis—Prednisone—multiple sclerosis	9.29e-05	0.000588	CcSEcCtD
Fosinopril—Vision blurred—Methotrexate—multiple sclerosis	9.28e-05	0.000587	CcSEcCtD
Fosinopril—Anorexia—Prednisone—multiple sclerosis	9.16e-05	0.00058	CcSEcCtD
Fosinopril—Ill-defined disorder—Methotrexate—multiple sclerosis	9.13e-05	0.000578	CcSEcCtD
Fosinopril—Anaemia—Methotrexate—multiple sclerosis	9.1e-05	0.000576	CcSEcCtD
Fosinopril—Feeling abnormal—Betamethasone—multiple sclerosis	9.1e-05	0.000576	CcSEcCtD
Fosinopril—Feeling abnormal—Dexamethasone—multiple sclerosis	9.1e-05	0.000576	CcSEcCtD
Fosinopril—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.03e-05	0.000571	CcSEcCtD
Fosinopril—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.03e-05	0.000571	CcSEcCtD
Fosinopril—Hypersensitivity—Triamcinolone—multiple sclerosis	8.96e-05	0.000567	CcSEcCtD
Fosinopril—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.94e-05	0.000566	CcSEcCtD
Fosinopril—Malaise—Methotrexate—multiple sclerosis	8.88e-05	0.000562	CcSEcCtD
Fosinopril—Vertigo—Methotrexate—multiple sclerosis	8.85e-05	0.00056	CcSEcCtD
Fosinopril—Leukopenia—Methotrexate—multiple sclerosis	8.81e-05	0.000558	CcSEcCtD
Fosinopril—Urticaria—Dexamethasone—multiple sclerosis	8.77e-05	0.000555	CcSEcCtD
Fosinopril—Urticaria—Betamethasone—multiple sclerosis	8.77e-05	0.000555	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Prednisone—multiple sclerosis	8.76e-05	0.000554	CcSEcCtD
Fosinopril—Dizziness—Prednisolone—multiple sclerosis	8.75e-05	0.000554	CcSEcCtD
Fosinopril—Asthenia—Triamcinolone—multiple sclerosis	8.73e-05	0.000552	CcSEcCtD
Fosinopril—Body temperature increased—Betamethasone—multiple sclerosis	8.73e-05	0.000552	CcSEcCtD
Fosinopril—Body temperature increased—Dexamethasone—multiple sclerosis	8.73e-05	0.000552	CcSEcCtD
Fosinopril—Abdominal pain—Dexamethasone—multiple sclerosis	8.73e-05	0.000552	CcSEcCtD
Fosinopril—Abdominal pain—Betamethasone—multiple sclerosis	8.73e-05	0.000552	CcSEcCtD
Fosinopril—Asthenia—Methylprednisolone—multiple sclerosis	8.71e-05	0.000551	CcSEcCtD
Fosinopril—Insomnia—Prednisone—multiple sclerosis	8.7e-05	0.00055	CcSEcCtD
Fosinopril—Paraesthesia—Prednisone—multiple sclerosis	8.63e-05	0.000546	CcSEcCtD
Fosinopril—Pruritus—Triamcinolone—multiple sclerosis	8.61e-05	0.000545	CcSEcCtD
Fosinopril—Cough—Methotrexate—multiple sclerosis	8.59e-05	0.000544	CcSEcCtD
Fosinopril—Pruritus—Methylprednisolone—multiple sclerosis	8.59e-05	0.000543	CcSEcCtD
Fosinopril—Dyspepsia—Prednisone—multiple sclerosis	8.46e-05	0.000536	CcSEcCtD
Fosinopril—Chest pain—Methotrexate—multiple sclerosis	8.38e-05	0.00053	CcSEcCtD
Fosinopril—Myalgia—Methotrexate—multiple sclerosis	8.38e-05	0.00053	CcSEcCtD
Fosinopril—Arthralgia—Methotrexate—multiple sclerosis	8.38e-05	0.00053	CcSEcCtD
Fosinopril—Decreased appetite—Prednisone—multiple sclerosis	8.36e-05	0.000529	CcSEcCtD
Fosinopril—Rash—Prednisolone—multiple sclerosis	8.34e-05	0.000528	CcSEcCtD
Fosinopril—Dermatitis—Prednisolone—multiple sclerosis	8.33e-05	0.000527	CcSEcCtD
Fosinopril—Diarrhoea—Methylprednisolone—multiple sclerosis	8.31e-05	0.000526	CcSEcCtD
Fosinopril—Fatigue—Prednisone—multiple sclerosis	8.29e-05	0.000524	CcSEcCtD
Fosinopril—Headache—Prednisolone—multiple sclerosis	8.29e-05	0.000524	CcSEcCtD
Fosinopril—Discomfort—Methotrexate—multiple sclerosis	8.28e-05	0.000524	CcSEcCtD
Fosinopril—Constipation—Prednisone—multiple sclerosis	8.22e-05	0.00052	CcSEcCtD
Fosinopril—Confusional state—Methotrexate—multiple sclerosis	8.1e-05	0.000513	CcSEcCtD
Fosinopril—Dizziness—Triamcinolone—multiple sclerosis	8.05e-05	0.000509	CcSEcCtD
Fosinopril—Anaphylactic shock—Methotrexate—multiple sclerosis	8.04e-05	0.000508	CcSEcCtD
Fosinopril—Dizziness—Methylprednisolone—multiple sclerosis	8.03e-05	0.000508	CcSEcCtD
Fosinopril—Infection—Methotrexate—multiple sclerosis	7.98e-05	0.000505	CcSEcCtD
Fosinopril—Feeling abnormal—Prednisone—multiple sclerosis	7.92e-05	0.000501	CcSEcCtD
Fosinopril—Asthenia—Betamethasone—multiple sclerosis	7.92e-05	0.000501	CcSEcCtD
Fosinopril—Asthenia—Dexamethasone—multiple sclerosis	7.92e-05	0.000501	CcSEcCtD
Fosinopril—Thrombocytopenia—Methotrexate—multiple sclerosis	7.87e-05	0.000498	CcSEcCtD
Fosinopril—Gastrointestinal pain—Prednisone—multiple sclerosis	7.86e-05	0.000497	CcSEcCtD
Fosinopril—Nausea—Prednisolone—multiple sclerosis	7.86e-05	0.000497	CcSEcCtD
Fosinopril—Pruritus—Dexamethasone—multiple sclerosis	7.81e-05	0.000494	CcSEcCtD
Fosinopril—Pruritus—Betamethasone—multiple sclerosis	7.81e-05	0.000494	CcSEcCtD
Fosinopril—Hyperhidrosis—Methotrexate—multiple sclerosis	7.77e-05	0.000492	CcSEcCtD
Fosinopril—Vomiting—Triamcinolone—multiple sclerosis	7.74e-05	0.00049	CcSEcCtD
Fosinopril—Vomiting—Methylprednisolone—multiple sclerosis	7.72e-05	0.000488	CcSEcCtD
Fosinopril—Rash—Triamcinolone—multiple sclerosis	7.67e-05	0.000485	CcSEcCtD
Fosinopril—Dermatitis—Triamcinolone—multiple sclerosis	7.66e-05	0.000485	CcSEcCtD
Fosinopril—Anorexia—Methotrexate—multiple sclerosis	7.66e-05	0.000485	CcSEcCtD
Fosinopril—Rash—Methylprednisolone—multiple sclerosis	7.65e-05	0.000484	CcSEcCtD
Fosinopril—Dermatitis—Methylprednisolone—multiple sclerosis	7.65e-05	0.000484	CcSEcCtD
Fosinopril—Urticaria—Prednisone—multiple sclerosis	7.64e-05	0.000483	CcSEcCtD
Fosinopril—Headache—Triamcinolone—multiple sclerosis	7.62e-05	0.000482	CcSEcCtD
Fosinopril—Headache—Methylprednisolone—multiple sclerosis	7.61e-05	0.000481	CcSEcCtD
Fosinopril—Abdominal pain—Prednisone—multiple sclerosis	7.6e-05	0.000481	CcSEcCtD
Fosinopril—Body temperature increased—Prednisone—multiple sclerosis	7.6e-05	0.000481	CcSEcCtD
Fosinopril—Diarrhoea—Dexamethasone—multiple sclerosis	7.55e-05	0.000478	CcSEcCtD
Fosinopril—Diarrhoea—Betamethasone—multiple sclerosis	7.55e-05	0.000478	CcSEcCtD
Fosinopril—Hypotension—Methotrexate—multiple sclerosis	7.51e-05	0.000475	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.32e-05	0.000463	CcSEcCtD
Fosinopril—Dizziness—Dexamethasone—multiple sclerosis	7.3e-05	0.000462	CcSEcCtD
Fosinopril—Dizziness—Betamethasone—multiple sclerosis	7.3e-05	0.000462	CcSEcCtD
Fosinopril—Insomnia—Methotrexate—multiple sclerosis	7.27e-05	0.00046	CcSEcCtD
Fosinopril—Nausea—Triamcinolone—multiple sclerosis	7.23e-05	0.000457	CcSEcCtD
Fosinopril—Paraesthesia—Methotrexate—multiple sclerosis	7.22e-05	0.000457	CcSEcCtD
Fosinopril—Nausea—Methylprednisolone—multiple sclerosis	7.21e-05	0.000456	CcSEcCtD
Fosinopril—Dyspnoea—Methotrexate—multiple sclerosis	7.16e-05	0.000453	CcSEcCtD
Fosinopril—Somnolence—Methotrexate—multiple sclerosis	7.14e-05	0.000452	CcSEcCtD
Fosinopril—Hypersensitivity—Prednisone—multiple sclerosis	7.08e-05	0.000448	CcSEcCtD
Fosinopril—Dyspepsia—Methotrexate—multiple sclerosis	7.07e-05	0.000448	CcSEcCtD
Fosinopril—Vomiting—Dexamethasone—multiple sclerosis	7.02e-05	0.000444	CcSEcCtD
Fosinopril—Vomiting—Betamethasone—multiple sclerosis	7.02e-05	0.000444	CcSEcCtD
Fosinopril—Decreased appetite—Methotrexate—multiple sclerosis	6.98e-05	0.000442	CcSEcCtD
Fosinopril—Rash—Dexamethasone—multiple sclerosis	6.96e-05	0.00044	CcSEcCtD
Fosinopril—Rash—Betamethasone—multiple sclerosis	6.96e-05	0.00044	CcSEcCtD
Fosinopril—Dermatitis—Betamethasone—multiple sclerosis	6.95e-05	0.00044	CcSEcCtD
Fosinopril—Dermatitis—Dexamethasone—multiple sclerosis	6.95e-05	0.00044	CcSEcCtD
Fosinopril—Fatigue—Methotrexate—multiple sclerosis	6.93e-05	0.000438	CcSEcCtD
Fosinopril—Headache—Dexamethasone—multiple sclerosis	6.92e-05	0.000438	CcSEcCtD
Fosinopril—Headache—Betamethasone—multiple sclerosis	6.92e-05	0.000438	CcSEcCtD
Fosinopril—Asthenia—Prednisone—multiple sclerosis	6.9e-05	0.000436	CcSEcCtD
Fosinopril—Pain—Methotrexate—multiple sclerosis	6.87e-05	0.000435	CcSEcCtD
Fosinopril—Pruritus—Prednisone—multiple sclerosis	6.8e-05	0.00043	CcSEcCtD
Fosinopril—Feeling abnormal—Methotrexate—multiple sclerosis	6.62e-05	0.000419	CcSEcCtD
Fosinopril—Diarrhoea—Prednisone—multiple sclerosis	6.58e-05	0.000416	CcSEcCtD
Fosinopril—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.57e-05	0.000416	CcSEcCtD
Fosinopril—Nausea—Dexamethasone—multiple sclerosis	6.56e-05	0.000415	CcSEcCtD
Fosinopril—Nausea—Betamethasone—multiple sclerosis	6.56e-05	0.000415	CcSEcCtD
Fosinopril—Urticaria—Methotrexate—multiple sclerosis	6.38e-05	0.000404	CcSEcCtD
Fosinopril—Dizziness—Prednisone—multiple sclerosis	6.36e-05	0.000402	CcSEcCtD
Fosinopril—Abdominal pain—Methotrexate—multiple sclerosis	6.35e-05	0.000402	CcSEcCtD
Fosinopril—Body temperature increased—Methotrexate—multiple sclerosis	6.35e-05	0.000402	CcSEcCtD
Fosinopril—Vomiting—Prednisone—multiple sclerosis	6.11e-05	0.000387	CcSEcCtD
Fosinopril—Rash—Prednisone—multiple sclerosis	6.06e-05	0.000384	CcSEcCtD
Fosinopril—Dermatitis—Prednisone—multiple sclerosis	6.06e-05	0.000383	CcSEcCtD
Fosinopril—Headache—Prednisone—multiple sclerosis	6.02e-05	0.000381	CcSEcCtD
Fosinopril—Hypersensitivity—Methotrexate—multiple sclerosis	5.92e-05	0.000375	CcSEcCtD
Fosinopril—Asthenia—Methotrexate—multiple sclerosis	5.76e-05	0.000365	CcSEcCtD
Fosinopril—Nausea—Prednisone—multiple sclerosis	5.71e-05	0.000361	CcSEcCtD
Fosinopril—Pruritus—Methotrexate—multiple sclerosis	5.68e-05	0.00036	CcSEcCtD
Fosinopril—Diarrhoea—Methotrexate—multiple sclerosis	5.5e-05	0.000348	CcSEcCtD
Fosinopril—Dizziness—Methotrexate—multiple sclerosis	5.31e-05	0.000336	CcSEcCtD
Fosinopril—Vomiting—Methotrexate—multiple sclerosis	5.11e-05	0.000323	CcSEcCtD
Fosinopril—Rash—Methotrexate—multiple sclerosis	5.07e-05	0.000321	CcSEcCtD
Fosinopril—Dermatitis—Methotrexate—multiple sclerosis	5.06e-05	0.00032	CcSEcCtD
Fosinopril—Headache—Methotrexate—multiple sclerosis	5.03e-05	0.000319	CcSEcCtD
Fosinopril—Nausea—Methotrexate—multiple sclerosis	4.77e-05	0.000302	CcSEcCtD
Fosinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	3.38e-05	0.0747	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—SLC30A7—multiple sclerosis	2.85e-05	0.0629	CbGpPWpGaD
Fosinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	1.99e-05	0.044	CbGpPWpGaD
Fosinopril—ACE—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	1.64e-05	0.0363	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—BCHE—multiple sclerosis	1.52e-05	0.0336	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	8.89e-06	0.0197	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—POMC—multiple sclerosis	7.85e-06	0.0174	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	7.26e-06	0.0161	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	6.74e-06	0.0149	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—SLC30A7—multiple sclerosis	5.37e-06	0.0119	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.08e-06	0.0112	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.71e-06	0.0104	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.52e-06	0.00999	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—PABPC1—multiple sclerosis	4.35e-06	0.00961	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—RPL5—multiple sclerosis	3.92e-06	0.00867	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.69e-06	0.00816	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.43e-06	0.00757	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.92e-06	0.00645	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—BCHE—multiple sclerosis	2.87e-06	0.00635	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.71e-06	0.00599	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.58e-06	0.0057	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.39e-06	0.00529	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.83e-06	0.00404	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.7e-06	0.00375	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—POMC—multiple sclerosis	1.48e-06	0.00328	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—CCL2—multiple sclerosis	1.45e-06	0.00321	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.29e-07	0.00205	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.62e-07	0.00191	CbGpPWpGaD
